Rivastigmine to Prevent Recurrence of Antimuscarinic Delirium

NCT06399679 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

42

Enrollment

OTHER

Sponsor class

Conditions

Anticholinergic Toxicity

Interventions

DRUG: Rivastigmine
DRUG: Placebo

Sponsor

Washington University School of Medicine

Collaborators

[object Object]